For example, increased EGFR and SFK activity was detected in association with increased tumor cell proliferation, invasion, and metastasis in tumor biopsies from patients with intrinsic or acquired vemurafenib resistance, and EGFR inhibitors cooperated with BRAFi to block the growth of the resistant cells in vitro and in vivo [64]. The gene discussed is EGFR; the disease is neoplasm.